Evaluation of a combinatorial approach to prion inactivation using an oxidizing agent, SDS, and proteinase K

BMC Veterinary Research

Justin J Greenlee²  Eric M Nicholson²  Jodi D Smith¹ 

[1] Department of Veterinary Pathology, College of Veterinary Medicine, Iowa State University, Ames, IA 50011, USA;Virus and Prion Research Unit, National Animal Disease Center, USDA, Agricultural Research Service, 1920 Dayton Ave, Ames, IA 50010, USA

关键词: Sodium percarbonate;    Sodium dodecyl sulfate;    Scrapie;    Proteinase;    Prion;    Inactivation;   

Others  :  1119488
DOI  :  10.1186/1746-6148-9-151

 received in 2013-02-27, accepted in 2013-07-24,  发布年份 2013

【 摘 要 】

Background

Prions demonstrate an unusual resistance to methods effective at inactivating conventional microorganisms. This has resulted in a very tangible and difficult infection control challenge to the medical and veterinary communities, as well as animal agriculture and related industries. Currently accepted practices of harsh chemical treatments such as prolonged exposure to sodium hydroxide or sodium hypochlorite, or autoclaving are not suitable in many situations. Less caustic and more readily applicable treatments to contaminated environments are therefore desirable. We recently demonstrated that exposure of the RML scrapie agent to a commercial product containing sodium percarbonate (SPC-P) with or without sodium dodecyl sulfate (SDS) rendered PrP^Sc sensitive to proteinase K (PK), but did not eliminate infectivity. The current study was designed to evaluate the efficacy of a combinatorial approach to inactivating prions by exposing RML-positive brain homogenate to SPC-P and SDS followed by PK. Treated samples were evaluated for PrP^Sc-immunoreactivity by western blot, and residual infectivity by mouse bioassay.

Results

Treatment of infected brain homogenate with SPC-P and SDS followed by PK exposure resulted in a 4–5 log₁₀ reduction in infectivity when bioassayed in tga20 mice.

Conclusions

This study demonstrates that exposure of the RML scrapie agent to SPC-P and SDS followed by PK markedly reduces, but does not eliminate infectivity. The results of this study encourage further investigation into whether consecutive or concomitant exposure to sodium percarbonate, SDS, and a protease may serve as a viable and non-caustic option for prion inactivation.

【 授权许可】

   
2013 Smith et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Prusiner SB: Prions. Proc Nat Acad Sci USA 1998, 95(23):13363-13383.
• [2]Gambetti P, Dong Z, Yuan J, Xiao X, Zheng M, Alshekhlee A, Castellani R, Cohen M, Barria MA, Gonzalez-Romero D, Belay ED, Schonberger LB, Marder K, Harris C, Burke JR, Montine T, Wisniewski T, Dickson DW, Soto C, Hulette CM, Mastrianni JA, Kong Q, Zou WQ: A novel human disease with abnormal prion protein sensitive to protease. Ann Neurol 2008, 63(6):697-708.
• [3]Colby D, Prusiner SB: Prions. Cold Spring Harb Perspect Biol 2011., 3epub a006833
• [4]Cronier SGN, Tattum MH, Jackson GS, Clarke AR, Colligne J, Wadsworth JDF: Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin. Biochem J 2008, 416:297-305.
• [5]Miyazawa K, Emmerling K, Manuelidis L: High CJD infectivity remains after prion protein is destroyed. J Cell Biochem 2011, 112(12):3630-3637.
• [6]Taylor DM: Inactivation of transmissible degenerative encephalopathy agents: a review. Vet J 2000, 159(1):10-17.
• [7]Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A, McCardle L, Chree A, Hope J, Birkett C, Cousens S, Fraser H, Bostock CJ: Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997, 389(6650):498-501.
• [8]Collinge J, Sidle KC, Meads J, Ironside J, Hill AF: Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 1996, 383(6602):685-690.
• [9]Wilesmith JW, Wells GA, Cranwell MP, Ryan JB: Bovine spongiform encephalopathy: epidemiological studies. Vet Rec 1988, 123(25):638-644.
• [10]Detwiler LA, Baylis M: The epidemiology of scrapie. Rev Sci Tech 2003, 22(1):121-143.
• [11]Sigurdson CJ: A prion disease of cervids: chronic wasting disease. Vet Res 2008, 39(4):41.
• [12]WHO: WHO infection control guidelines for transmissible spongiform encephalopathies. Geneva: WHO/CDS/CSR/APH/20003; 1999:29-32.
• [13]US Department of Health and Human Services: Biosafety in Microbiological and Biomedical Laboratories. 5th edition. Washington DC: US Government Printing Office; 2007.
• [14]Walker AS, Inderlied CB, Kingsbury DT: Conditions for the chemical and physical inactivation of the K, Fu. strain of the agent of Creutzfeldt-Jakob disease. Am J Pub Health 1983, 73(6):661-665.
• [15]Millson GC, Hunter GD, Kimberlin RH: The physico-chemical nature of the scrapie agent. In Slow Virus Diseases of Animals and Man. Volume 44. Edited by Kimberlin RH. Amsterdam: North-Holland; 1976:243-264.
• [16]Lemmer K, Mielke M, Kratzel C, Joncic M, Oezel M, Pauli G, Beekes M: Decontamination of surgical instruments from prions, II. In vivo findings with a model system for testing the removal of scrapie infectivity from steel surfaces. J Gen Virol 2008, 89(Pt 1):348-358.
• [17]Beekes M, Lemmer K, Thomzig A, Joncic M, Tintelnot K, Mielke M: Fast, broad-range disinfection of bacteria, fungi, viruses and prions. J Gen Virol 2010, 91(Pt 2):580-589.
• [18]Prusiner SB, McKinley MP, Groth DF, Bowman KA, Mock NI, Cochran SP, Masiarz FR: Scrapie agent contains a hydrophobic protein. Proc Natl Acad Sci USA 1981, 78(11):6675-6679.
• [19]Cho HJ: Inactivation of the scrapie agent by pronase. Can J Comp Med 1983, 47(4):494-496.
• [20]McLeod AH, Murdoch H, Dickinson J, Dennis MJ, Hall GA, Buswell CM, Carr J, Taylor DM, Sutton JM, Raven ND: Proteolytic inactivation of the bovine spongiform encephalopathy agent. Biochem Biophys Res Comm 2004, 317(4):1165-1170.
• [21]Dickinson J, Murdoch H, Dennis MJ, Hall GA, Bott R, Crabb WD, Penet C, Sutton JM, Raven ND: Decontamination of prion protein (BSE301V) using a genetically engineered protease. J Hosp Infect 2009, 72(1):65-70.
• [22]Pilon JL, Nash PB, Arver T, Hoglund D, Vercauteren KC: Feasibility of infectious prion digestion using mild conditions and commercial subtilisin. J Virol Methods 2009, 161(1):168-172.
• [23]Jackson GS, McKintosh E, Flechsig E, Prodromidou K, Hirsch P, Linehan J, Brandner S, Clarke AR, Weissmann C, Collinge J: An enzyme-detergent method for effective prion decontamination of surgical steel. J Gen Virol 2005, 86(Pt 3):869-878.
• [24]Brown P, Gibbs CJ Jr, Amyx HL, Kingsbury DT, Rohwer RG, Sulima MP, Gajdusek DC: Chemical disinfection of Creutzfeldt-Jakob disease virus. New Engl J Med 1982, 306(21):1279-1282.
• [25]Fichet G, Antloga K, Comoy E, Deslys JP, McDonnell G: Prion inactivation using a new gaseous hydrogen peroxide sterilisation process. J Hosp Infect 2007, 67(3):278-286.
• [26]Brown P, Rohwer RG, Green EM, Gajdusek DC: Effect of chemicals, heat, and histopathologic processing on high-infectivity hamster-adapted scrapie virus. J Infect Dis 1982, 145(5):683-687.
• [27]Taylor DM: Resistance of the ME7 scrapie agent to peracetic acid. Vet Microbiol 1991, 27(1):19-24.
• [28]Fichet G, Comoy E, Duval C, Antloga K, Dehen C, Charbonnier A, McDonnell G, Brown P, Lasmezas CI, Deslys JP: Novel methods for disinfection of prion-contaminated medical devices. Lancet 2004, 364(9433):521-526.
• [29]Smith JD, Nicholson EM, Foster GH, Greenlee JJ: Exposure of RML scrapie agent to a sodium percarbonate-based product and sodium dodecyl sulfate renders PrPSc protease sensitive but does not eliminate infectivity. BMC Vet Res 2013. 10.1186/1746-6148-9-8
• [30]Fischer M, Rulicke T, Raeber A, Sailer A, Moser M, Oesch B, Brandner S, Aguzzi A, Weissmann C: Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J 1996, 15(6):1255-1264.
• [31]Brown P, Rohwer RG, Gajdusek DC: Newer data on the inactivation of scrapie virus or Creutzfeldt-Jakob disease virus in brain tissue. J Infect Dis 1986, 153(6):1145-1148.
• [32]Taylor DM, Fraser H, McConnell I, Brown DA, Brown KL, Lamza KA, Smith GR: Decontamination studies with the agents of bovine spongiform encephalopathy and scrapie. Arch Virol 1994, 139(3–4):313-326.
• [33]Unal A, Thyer J, Uren E, Middleton D, Braun M, Maher D: Investigation by bioassay of the efficacy of sodium hydroxide treatment on the inactivation of mouse-adapted scrapie. Biologicals 2007, 35(3):161-164.
• [34]Bruederle CE, Hnasko RM, Kraemer T, Garcia RA, Haas MJ, Marmer WN, Carter JM: Prion infected meat-and-bone meal is still infectious after biodiesel production. PLoS One 2008, 3(8):e2969.
• [35]Gonzalez L, Thorne L, Jeffrey M, Martin S, Spiropoulos J, Beck KE, Lockey RW, Vickery CM, Holder T, Terry L: Infectious titres of sheep scrapie and bovine spongiform encephalopathy agents cannot be accurately predicted from quantitative laboratory test results. J Gen Virol 2012, 93(Pt 11):2518-2527.
• [36]Manuelidis L: A 25 nm virion is the likely cause of transmissible spongiform encephalopathies. J Cell Biochem 2007, 100(4):897-915.
• [37]Head MW, Knight R, Zeidler M, Yull H, Barlow A, Ironside JW: A case of protease sensitive prionopathy in a patient in the UK. Neuropathol Appl Neurobiol 2009, 35(6):628-632.